Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia
Fan Zhang,1 Tianmei Si,2,3 Chiun-Fang Chiou,4 Anthony WF Harris,5 Chang Yoon Kim,6 Padmashree Jahagirdar,7 Steve Ascher8 1Xian Janssen Pharmaceuticals, Beijing, People’s Republic of China; 2Department of Clinical Psychopharmacology, Peking University Institute of Mental Health, Beijing, P...
Saved in:
Main Authors: | Zhang F, Si T, Chiou CF, Harris AWF, Kim CY, Jahagirdar P, Ascher S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/c4f7c99c20f64a76bfe01849b0f32994 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
by: Si T, et al.
Published: (2019) -
Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability
by: Gattaz WF, et al.
Published: (2020) -
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review
by: Emsley R, et al.
Published: (2018) -
Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
by: Takahashi N, et al.
Published: (2013) -
Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study
by: Si TM, et al.
Published: (2015)